Sunshine Biopharma
SBFM
6 hedge funds and large institutions have $760K invested in Sunshine Biopharma in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, reducing their positions, and 4 closing their positions.
0% less ownership
Funds ownership: 0% → 0% (-0%)
14% less funds holding
Funds holding: 7 → 6 (-1)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
79% less capital invested
Capital invested by funds: $3.55M → $760K (-$2.79M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$1.37M |
| 2 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$97.7K |
| 3 |
DWM
Dakota Wealth Management
Palm Beach Gardens,
Florida
|
+$48.8K |
| 4 |
VF
Virtu Financial
New York
|
+$48.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$1.56M |
| 2 |
EAM
Empery Asset Management
New York
|
-$1.1M |
| 3 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$720K |
| 4 |
Jane Street
New York
|
-$31K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BCM
1
Bridgeway Capital Management
Houston,
Texas
| $614K | +$1.37M | +28 | New |
|
|
VF
2
Virtu Financial
New York
| $52K | +$48.8K | +1 | +100% |
|
|
TSS
3
Two Sigma Securities
New York
| $22K | – | – | – |
|
|
DWM
4
Dakota Wealth Management
Palm Beach Gardens,
Florida
| $22K | +$48.8K | +1 | New |
|
5
Geode Capital Management
Boston,
Massachusetts
| $21K | – | – | – |
|
|
TRCT
6
Tower Research Capital (TRC)
New York
| $9K | – | – | – |
|
7
Osaic Holdings
Scottsdale,
Arizona
| $8K | – | – | – |
|
8
Morgan Stanley
New York
| $7K | – | – | – |
|
9
Bank of America
Charlotte,
North Carolina
| $4K | – | – | – |
|
10
National Bank of Canada
Montreal,
Quebec, Canada
| $1K | – | – | – |
|
|
FDCDDQ
11
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $85 | – | – | – |
|
|
12
Bank of Montreal
Toronto,
Ontario, Canada
| $40 | +$97.7K | +2 | New |
|
|
AC
13
Armistice Capital
New York
| – | -$1.56M | -32 | Closed |
|
|
EAM
14
Empery Asset Management
New York
| – | -$1.1M | -23 | Closed |
|
|
15
Hudson Bay Capital Management
Stamford,
Connecticut
| – | -$720K | -16 | Closed |
|
|
16
Jane Street
New York
| – | -$31K | -1 | Closed |
|
SBFM Hedge Fund Activity: Q2 2022 in Review
6 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Sunshine Biopharma (SBFM) for Q2 2022, worth a combined $760K — down 79% from $3.55M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of SBFM and 3 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 1 added.
The largest buyer was Bridgeway Capital Management, opening a new position worth an estimated $1.37M. The largest seller was Armistice Capital, exiting entirely with an estimated $1.56M sold.
- 6 institutional investors held Sunshine Biopharma (SBFM) as of Q2 2022, down from 7 in Q1 2022.
- Funds reported $760K of Sunshine Biopharma stock for Q2 2022, down 79% quarter-over-quarter.
- 3 funds opened new Sunshine Biopharma positions in Q2 2022 and 4 closed out, a net change of -1 holder.
- The largest Sunshine Biopharma buyer in Q2 2022 was Bridgeway Capital Management, an estimated $1.37M added.
- The largest Sunshine Biopharma seller in Q2 2022 was Armistice Capital, an estimated $1.56M sold.
Based on aggregated 13F filings for Q2 2022.